Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Food and Drug Administration approvals in phase 3 Cancer clinical trials.
Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Abi Jaoude J, et al. Among authors: pasalic d. BMC Cancer. 2021 Jun 12;21(1):695. doi: 10.1186/s12885-021-08457-5. BMC Cancer. 2021. PMID: 34118915 Free PMC article. Clinical Trial.
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, Liao Z, Erasmus JJ, Nguyen QN. Pasalic D, et al. Head Neck. 2020 Aug;42(8):1939-1953. doi: 10.1002/hed.26117. Epub 2020 Mar 4. Head Neck. 2020. PMID: 32129548 Free PMC article.
SABR for Skull Base Malignancies: A Systematic Analysis of Set-Up and Positioning Accuracy.
Mesko S, Wang H, Tung S, Wang C, Pasalic D, Ning MS, Pezzi TA, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Su SY, Hanna E, Phan J. Mesko S, et al. Among authors: pasalic d. Pract Radiat Oncol. 2020 Sep-Oct;10(5):363-371. doi: 10.1016/j.prro.2020.02.016. Epub 2020 Mar 30. Pract Radiat Oncol. 2020. PMID: 32240823
Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy.
Pasalic D, Ludmir EB, Allen PK, Thaker NG, Chapman BV, Hanna EY, Su SY, Ferrarotto R, Glisson BS, Reddy JP, Brandon Gunn G, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Garden AS, Frank SJ. Pasalic D, et al. Radiother Oncol. 2020 Jul;148:258-266. doi: 10.1016/j.radonc.2020.05.007. Epub 2020 May 15. Radiother Oncol. 2020. PMID: 32417351
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR Jr, Minsky BD, Ludmir EB. Pasalic D, et al. Eur J Cancer. 2020 Sep;136:176-185. doi: 10.1016/j.ejca.2020.06.015. Epub 2020 Jul 20. Eur J Cancer. 2020. PMID: 32702645 Free PMC article. Review.
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials.
Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR Jr, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Lin TA, et al. Among authors: pasalic d. Cancers (Basel). 2020 Sep 16;12(9):2636. doi: 10.3390/cancers12092636. Cancers (Basel). 2020. PMID: 32947844 Free PMC article.
Performance Status Restriction in Phase III Cancer Clinical Trials.
Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB. Abi Jaoude J, et al. Among authors: pasalic d. J Natl Compr Canc Netw. 2020 Oct 1;18(10):1322-1326. doi: 10.6004/jnccn.2020.7578. Print 2020 Oct. J Natl Compr Canc Netw. 2020. PMID: 33022640 Free PMC article.
The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy.
Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC. Augustyn A, et al. Among authors: pasalic d. Leuk Lymphoma. 2021 Jun;62(6):1361-1369. doi: 10.1080/10428194.2020.1869965. Epub 2021 Jan 22. Leuk Lymphoma. 2021. PMID: 33480830 Free PMC article.
66 results